AusPAR: Denosumab
Australian Public Assessment Report
Device/Product Name
Prolia
Active ingredients
Denosumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-01353-1-5
Submission Type
Major variation; extension of indications
Decision
Approved